Drawing for EVERNORTH THERAPY LINK

USPTO serial 99673804

EVERNORTH THERAPY LINK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RODRIGUEZ, ALEJANDRO NMN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with EVERNORTH THERAPY LINK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Troy E. Larson

Two Liberty Place1601 Chestnut Street, TL7Philadelphia, PA 19192

Goods and services

ClassDescriptionStatusFirst use
035Specialty retail pharmacy services featuring pharmaceuticals, biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products; Business consulting and management in the field of clinical trials, namely, providing information management services; Data collection services for business purposes in the nature of extracting, summarizing, analyzing and validating information from medical records in the field of clinical trials management; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugsACTIVE—
036Pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; Providing information about healthcare insurance plansACTIVE—
044Providing medical information in the field of cell and gene therapy; Providing healthcare information in the field of cell and gene therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 9, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2026DOCKASSIGNED TO EXAMINER—
Jun 25, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance